SenesTech, Inc. (SNES) Latest Company News

Oct 19, 2026, 19:00 UTC
Glenbrook Capital Management said it owns more than 30% of SenesTech's outstanding shares.
Source:
- prnewswire.com
Oct 19, 2026, 12:00 UTC
SenesTech reported an 88% reduction in rat activity in its Chicago pilot area and a 36% decline in rodent-related 311 calls, while citywide calls increased.
Source:
- globenewswire.com
Oct 15, 2026, 12:00 UTC
SenesTech reported preliminary third-quarter 2026 revenue of $1.1 million, a company record and 40% higher sequentially.
Source:
- prnewswire.com
Sep 25, 2026, 21:19 UTC
Stark Focus Group, Inc. appointed Matthew Szot as Chief Financial Officer, effective October 8, 2026.
Sep 23, 2026, 12:30 UTC
SenesTech, Inc. announced that its Evolve rodent birth control products will soon be available through Grove Collaborative's online marketplace, expanding its third-party e-commerce distribution.
Source:
- prnewswire.com
Sep 11, 2026, 01:45 UTC
SenesTech CEO and Director Michael Edell acquired 2,000 shares of SenesTech common stock on September 9, 2026, at prices between $0.85 and $0.89 per share for a total of $1,740, bringing his direct beneficial ownership to 8,000 shares.
Source:
- investing.com
Aug 27, 2026, 20:15 UTC
SenesTech, Inc. announced that its Board of Directors granted an inducement equity award to John Karabees in connection with his appointment as Executive Vice President, Sales.
Source:
- prnewswire.com
Aug 5, 2026, 20:05 UTC
SenesTech reported record Q2 2026 revenue and gross margin, with revenue rising 56% sequentially and gross margin reaching 73.6% in the first full quarter of in-house Amazon management.
Source:
- prnewswire.com
- defenseworld.net
Aug 5, 2026, 12:30 UTC
SenesTech announced the addition of assessment services to help B2B customers better understand rodent infestations, complementing its existing implementation and deployment services.
Source:
- prnewswire.com
Jun 4, 2026, 12:00 UTC
SenesTech expands distribution of its Evolve Rodent Birth Control products into Bermuda through a distribution agreement with Animal and Garden House.
Source:
- prnewswire.com

SNES

Glenbrook Capital Management said it owns more than 30% of SenesTech's outstanding shares.

SenesTech reported an 88% reduction in rat activity in its Chicago pilot area and a 36% decline in rodent-related 311 calls, while citywide calls increased.

SenesTech reported preliminary third-quarter 2026 revenue of $1.1 million, a company record and 40% higher sequentially.

Stark Focus Group, Inc. appointed Matthew Szot as Chief Financial Officer, effective October 8, 2026.

SenesTech, Inc. announced that its Evolve rodent birth control products will soon be available through Grove Collaborative's online marketplace, expanding its third-party e-commerce distribution.

SenesTech CEO and Director Michael Edell acquired 2,000 shares of SenesTech common stock on September 9, 2026, at prices between $0.85 and $0.89 per share for a total of $1,740, bringing his direct beneficial ownership to 8,000 shares.

SenesTech, Inc. announced that its Board of Directors granted an inducement equity award to John Karabees in connection with his appointment as Executive Vice President, Sales.

SenesTech reported record Q2 2026 revenue and gross margin, with revenue rising 56% sequentially and gross margin reaching 73.6% in the first full quarter of in-house Amazon management.

SenesTech announced the addition of assessment services to help B2B customers better understand rodent infestations, complementing its existing implementation and deployment services.

SenesTech expands distribution of its Evolve Rodent Birth Control products into Bermuda through a distribution agreement with Animal and Garden House.